Arvind Dasari, MD, MS
@adasarimd
Followers
793
Following
6
Statuses
9
Professor, @MDAndersonNews GI Oncology; Neuroendocrine Tumors and Colorectal Cancer. Tweets are my own.
Houston, TX
Joined January 2019
RT @jonathanloree: A3: SUNLIGHT Impact (2/2) It also means in the past 6 months we have data that will improve survival for mCRC to 7.7 mon…
0
4
0
RT @CathyEngMD: Day #3 #GI23 #crc and anal #cancer updates! Come visit our #QOL data from phase 3 trial #FRESCO2 @hutchmed of #fruquinitinb…
0
5
0
RT @CathyEngMD: #GI23 #ascogi23 @adasarimd @hutchmed #FRESCO-2 #Fruquintinib #QOL Board D4 Happening now: #teamwork #mentorship #workfamily…
0
6
0
NRG-GI008, CIRCULATE-US For St III & high risk st II Colon cancer All pts get ctDNA test 6-8 wks after surgery If ctDNA +ve, randomized to 📌 CAPOX or FOLFOX --SOC or 📌FOLFOXIRI--stronger chemo To see if strong chemo➡️to better outcomes in ctDNA+ve pts #CRCTrialsChat 3/3
2
13
23
NRG-GI008, CIRCULATE-US For St III & some st II Colon ca All pts get ctDNA test after surgery If ctDNA -ve, randomized to 📌 FOLFOX/CAPOX or 📌No chemo with serial ctDNA testing If ctDNA+ve in the no chemo arm later, cross-over to the ctDNA +ve arm #CRCTrialsChat 2/3
5
18
43
NRG-GI008, CIRCULATE-US is a #clinicaltrial for st III & high-risk st II colon cancer 📌To see if chemo is needed for all or only some patients & 📌if chemo is needed, what kind? based on #ctDNA +ve or -ve after surgery More info👇👇 #CRCTrialsChat 1/3
1
8
16
RT @VanMorrisMD: It takes a village! Management of metastatic CRC has become ⬆️complex and requires a multidisciplinary team of caregivers.…
0
19
0
RT @PamelaKunzMD: 🔑 points: 1⃣CapeTem was associated with a signif improvement in PFS compared to Tem 2⃣Median PFS & RR with CapeTem are t…
0
7
0